EXPRES2ION
ExpreS2ion Biotechnologies is a biotech company within protein production in Drosophila Schneider-2 (S2) cells.
EXPRES2ION
Industry:
Biotechnology Medical
Founded:
2010-01-01
Address:
Hørsholm, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.expres2ionbio.com
Total Employee:
11+
Status:
Active
Contact:
+45 2222 1019
Email Addresses:
[email protected]
Total Funding:
2.7 M SEK
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
AI4R
AI4R engages in digital real-time autoradiography, a new-generation imaging solutions for preclinical studies.
DNAlytics
DNAlytics develops innovative data-driven precision medicine solutions.
Gate2Brain
Gate2Brain is a biotech company to improve drug delivery with peptide-based patented technology.
OmniSpirant
OmniSpirant develops regenerative gene therapies with the potential to transform respiratory medicine.
Current Employees Featured
Founder
Investors List
Horizon 2020
Horizon 2020 investment in Grant - ExpreS2ion
Official Site Inspections
http://www.expres2ionbio.com Semrush global rank: 2.56 M Semrush visits lastest month: 6.88 K
- Host name: linux118.unoeuro.com
- IP address: 94.231.103.63
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
More informations about "ExpreS2ion" on Search Engine
ExpreS2ion Biotechnologies - Wikipedia
ExpreS2ion Biotechnologies is a Danish biotechnology company specialised in the development of new vaccines and immunotherapy products based in Hørsholm, Denmark and listed on the Nasdaq First North Growth Market Sweden. ExpreS2ion is part of the PREVENT-nCoV consortium comprising AdaptVac (a joint-venture between ExpreS2ion Biotechnologies and the University of CopenhagenSee details»
ExpreS2ion - Crunchbase Company Profile & Funding
Last Funding Type Post-IPO Equity. Stock Symbol STO:EXPRS2. Company Type For Profit. Contact Email [email protected]. Phone Number +45 2222 1019. ExpreS2ion …See details»
ExpreS2ion strengthens its organization to further …
Hørsholm, Denmark, January 11, 2021 – ExpreS2ion Biotech Holding AB hereby announces that its affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") is …See details»
ExpreS2ion Biotechnologies - innovative vaccines for a healthier …
The MucoVax consortium, a collaboration between ExpreS2ion and University of Copenhagen, has been awarded an Innovation Fund Denmark (IFD) Grand Solutions …See details»
Proteins for life - ExpreS2ion Biotechnologies
Shareholder i n f o r m a t i o n. ExpreS2ion Biotech Holding AB’s share was listed at Nasdaq First North Growth Market on July 29, 2016. The trading name of the share is …See details»
Annual report 2019 - ExpreS2ion Biotechnologies
3 About ExpreS2ion Biotech Holding AB ExpreS2ion was established in 2010 as a technology spinout from the Danish pharmaceutical company Affitech A/S (formerly …See details»
History - ExpreS2ion Biotechnologies
Our History. ExpreS2ion Biotechnologies ApS was founded in 2010, based on a decade-long research on developing an optimised protein expression system using Drosophila …See details»
ExpreS2ion - Funding, Financials, Valuation & Investors
ExpreS2ion is funded by Horizon 2020. Which investors participated in the most funding rounds? Show. Unlock even more features with Crunchbase Pro. Start Your Free Trial. …See details»
ExpreS2ion Biotech : strengthens its organization to further …
Hørsholm, Denmark, January 11, 2021 - ExpreS2ion Biotech Holding AB hereby announces that its affiliate ExpreS2ion Biotechnologies ApS is reorganizing the company's top …See details»
2023 Half-year report Innovative vaccines for a healthier world
The ExpreS2 technology platform. The Company’s ExpreS2TM platform has been used successfully for the development and production of hard-to-express proteins for over a …See details»
News - ExpreS2ion Biotechnologies
Feb 28, 2018 Company presentation. Check out ExpreS2ion Biotechnologies in this short video. Making a difference within oncology and infectious diseases – and we are […] …See details»
ExpreS2ion - Contacts, Employees, Board Members, Advisors
ExpreS2ion Biotechnologies is a biotech company within protein production in Drosophila Schneider-2 (S2) cells.See details»
ExpreS2ion announces financial results for the fourth quarter and …
Hørsholm, Denmark, 8 February 2024 - ExpreS2ion Biotech Holding AB ("ExpreS2ion") today announces its fourth quarter and full-year financial results for 2023. The report is …See details»
Annual Report 2020 Proteins for life - ExpreS2ion Biotechnologies
Organization structure ExpreS2ion Biotech Holding AB Board of Directors ExpreS2ion Biotechnologies ApS 100% owned by AB CEO Commercial Customer Relations …See details»
EXPRES2ION BIOTECHNOLOGIES ApS - Front page - Ofir
ExpreS2ion is growing and has a low turnover rate. As of April 2021 we hired 7 new colleagues and we're now 25 employees. 8 of our 25 employees have been with …See details»
Interim report Q3 2023 Innovative vaccines for a healthier world
ExpreS2ion Biotech Holding AB Org. Nr. 559033-3729. Forward-looking statements and disclaimer. This report contains forward-looking statements. The words “believe”, …See details»
Meet Us - ExpreS2ion Biotechnologies
Meet Us. ExpreS 2 ion Biotechnologies is represented at the forthcoming partnering/investor events and scientific conferences – please feel free to reach out for a meeting at our …See details»
ExpreS2ion - Tech Stack, Apps, Patents & Trademarks
Apr 26, 2024 Organization. ExpreS2ion. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Active Tech Count 22. …See details»
Careers at ExpreS2ion - ExpreS2ion Biotechnologies
We are a flat organization with transparency in management and information flow. Impact. As a scale-up company; We have an ambition to do better – and you’ll get a chance to …See details»